O'Shaughnessy Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-128
Closed -$8K 2025
2019
Q4
$8K Buy
+128
New +$4.8K ﹤0.01% 1368

O'Shaughnessy Asset Management's BOLD Position: Q1 2020 in Review

O'Shaughnessy Asset Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 128 shares — an estimated $8K sold.

O'Shaughnessy Asset Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $8K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • O'Shaughnessy Asset Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 128 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $8K.
  • O'Shaughnessy Asset Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • O'Shaughnessy Asset Management's Audentes Therapeutics, Inc position peaked at $8K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2020, filed 13 May 2020.